DECAPEPTYL triptorelin acetate 100 micrograms/1 mL solution for injection in 1mL pre-filled syringe with integrated needle Australia - English - Department of Health (Therapeutic Goods Administration)

decapeptyl triptorelin acetate 100 micrograms/1 ml solution for injection in 1ml pre-filled syringe with integrated needle

ferring pharmaceuticals pty ltd - triptorelin acetate, quantity: 100 microgram (equivalent: triptorelin, qty 95.6 microgram/ml) - injection, solution - excipient ingredients: glacial acetic acid; water for injections; sodium chloride - decapeptyl 100 micrograms/1 ml is indicated for down-regulation and prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation for assisted reproductive technologies (art).,in clinical trials decapeptyl 100 micrograms/1 ml has been used in cycles where urinary and recombinant human follicle stimulating hormone (fsh) as well as human menopausal gonadotrophin (hmg) were used for stimulation.

ELIGARD leuprorelin acetate 30mg modified release injection syringe Australia - English - Department of Health (Therapeutic Goods Administration)

eligard leuprorelin acetate 30mg modified release injection syringe

mundipharma pty ltd - leuprorelin acetate, quantity: 30 mg - injection, modified release - excipient ingredients: n-methyl-2-pyrrolidone; polyglactin - prostate cancer,eligard 7.5mg 1 month, eligard 22.5mg 3 month, eligard 30mg 4 month and eligard 45mg 6 month are indicated for the:,? palliative treatment of advanced prostate cancer.,? treatment of high-risk localised and locally advanced hormone-dependent prostate cancer in combination with radiotherapy.

ELIGARD leuprorelin acetate 7.5mg modified release injection syringe Australia - English - Department of Health (Therapeutic Goods Administration)

eligard leuprorelin acetate 7.5mg modified release injection syringe

mundipharma pty ltd - leuprorelin acetate, quantity: 7.5 mg - injection, modified release - excipient ingredients: n-methyl-2-pyrrolidone; polyglactin - eligard 7.5mg 1 month, eligard 22.5mg 3 month, eligard 30mg 4 month and eligard 45mg 6 month are indicated for the:,? palliative treatment of advanced prostate cancer.,? treatment of high-risk localised and locally advanced hormone-dependent prostate cancer in combination with radiotherapy.1

Rekovelle European Union - English - EMA (European Medicines Agency)

rekovelle

ferring pharmaceuticals a/s - follitropin delta - anovulation - sex hormones and modulators of the genital system, - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle.

Elonva European Union - English - EMA (European Medicines Agency)

elonva

n.v. organon - corifollitropin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - sex hormones and modulators of the genital system, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program.elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).

Suprelorin 9.4 mg Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

suprelorin 9.4 mg

virbac (australia) pty ltd - deslorelin as deslorelin acetate - parenteral implant, device - deslorelin as deslorelin acetate ungrouped active 9.4 mg/im - endocrine system - dog - male - reducing testosterone production

Suprelorin 4.7 mg Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

suprelorin 4.7 mg

virbac (australia) pty ltd - deslorelin as deslorelin acetate - parenteral implant, device - deslorelin as deslorelin acetate ungrouped active 4.7 mg/im - endocrine system - dog - male - reducing testosterone production

ERLEADA Israel - English - Ministry of Health

erleada

j-c health care ltd - apalutamide - film coated tablets - apalutamide 60 mg - apalutamide - "erleada is indicated in adult men for the treatment of• metastatic hormone‐sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (adt)• non-metastatic castration-resistant prostate cancer (nm-crpc)."

ORILISSA TABLET Canada - English - Health Canada

orilissa tablet

abbvie corporation - elagolix (elagolix sodium) - tablet - 150mg - elagolix (elagolix sodium) 150mg - gonadotropin-releasing hormone antagonists

DECAPEPTYL DEPOT 22.5 MG Israel - English - Ministry of Health

decapeptyl depot 22.5 mg

ferring pharmaceuticals ltd - triptorelin as embonate - powder and solvent for suspension for injection - triptorelin as embonate 22.5 mg - triptorelin - symptomatic treatment of advanced hormone-dependent prostate cancer. as an alternative treatment, if orchiectomy or the administration of oestrogens are not indicated or are unacceptable to the patient. treatment of central precocious puberty (cpp) in children 2 years and older with an onset of cpp before 8 years in girls and 10 years in boys.